Journal of Clinical Lipidology

Article	Citations
Hypolipidemia is associated with the severity of COVID-19	251
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction	103
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group	70
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials	70
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association	68
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient	55
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy	50
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability	49
The association between triglycerides and incident cardiovascular disease: What is “optimal”?	42
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)	38
Ketogenic diets, not for everyone	38
A simplified diagnosis algorithm for dysbetalipoproteinemia	37
Saturated fats and cardiovascular health: Current evidence and controversies	36
PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study	36
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment	33
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial	32
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	24
HDL proteome remodeling associates with COVID-19 severity	22
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching	22
A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia	21
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial	21
A mechanism-based operational definition and classification of hypercholesterolemia	20
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association	20
Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events	20
Low levels of cholesterol and the cholesterol type are not associated with depression: Results of a cross-sectional NHANES study	20

Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity	20
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia	20
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials	19
Guidance for the diagnosis and treatment of hypolipidemia disorders	19
The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln)	19
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction	18
PCSK9 inhibition in clinical practice: Treatment patterns and attainment of lipid goals in a large health maintenance organization	18
Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia	18
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study	18
Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies	18
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia	17
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association	17
Real-world utilization of bempedoic acid in an academic preventive cardiology practice	17
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresi	17
Quantile-specific heritability of high-density lipoproteins with implications for precision medicine	17
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran	16
Association of high maternal triglyceride levels early and late in pregnancy with adverse outcomes: A retrospective cohort study	16
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia	15
Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort	14
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	14
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States	14
Gene–environment interaction between APOA5 c.553G>T and pregnancy in hypertriglyceridemia-induced acute pancreatitis	13
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes	13
Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)	13
Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia	13
Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease	13
Effect of pharmacist interventions on reducing low-density lipoprotein cholesterol (LDL-C) levels: A systematic review and meta-analysis	13
Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system	13
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program	12
Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis	12
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia	12
Statin use and fall-related hospitalizations among residents of long-term care facilities: A case-control study	11
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial	11
Familial hypercholesterolemia in Mexico: Initial insights from the national registry	11
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	11
Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic	10
Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy	10
The economic impact of familial hypercholesterolemia on productivity	10
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience	10
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia	10
Characterizing lipid profiles associated with asymptomatic intracranial arterial stenosis in rural-dwelling adults: A population-based study	10
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial	9
Lower triglyceride levels are associated with better endothelial function	9
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome	9
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association	9
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction	9
C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study	9
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects	9
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)	9
Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience	9

Characteristics and trends of PCSK9 inhibitor prescription fills in the United States	9
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis	8
Mustard oil and cardiovascular health: Why the controversy?	8
Functional profiling of LDLR variants: Important evidence for variant classification	8
Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)	8
Evolocumab in patients with homozygous familial hypercholesterolemia in India	8
Lipoprotein (a) is associated with poor long-term prognosis in patients aged 80 years and older with acute coronary syndrome	8
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis	8
JCL roundtable: Lipids and inflammation in atherosclerosis	8
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD	8
Misinterpreting data in lipidology in the era of COVID-19	8
The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation	8
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study	8
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	8
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India	8
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis	8
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)	8
Sex‐related differences in premature cardiovascular disease in familial hypercholesterolemia	8
The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants	7
Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention	7
Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study	7
Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial	7
Cholestasis as a dominating symptom of patients with CYP27A1 mutations: An analysis of 17 Chinese infants	7
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Pre	7
Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) – Results of a US national survey	7
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction	7
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis	7
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT	7
Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study	7
Free fatty acids, cardiovascular disease, and mortality in the Multi-Ethnic Study of Atherosclerosis	7
The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children	6
Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002–2016	6
Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia	6
Hyperlipidemia and risk for preclampsia	6
Are statins safe in patients with COVID-19?	6
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research	6
Extreme elevations of low-density lipoprotein cholesterol with very low carbohydrate, high fat diets	6
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey	6
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States	6
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia	6
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study	6
Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm	6
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis	6
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial	6
Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study	6
Chronic kidney disease and statin eligibility	6
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers	6
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers	6
Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses	6
Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia	6
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia	6
Effectiveness of medical nutrition therapy in the management of adult dyslipidemia: A systematic review and meta-analysis	6
Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes	6
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use	6
Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report	5
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy model	5
The changing pattern of statin use in people with dementia: A population-based study	5
Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals	5
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy	5
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective	5
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India	5
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case report	5
Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants	5
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	5
Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis	5
Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins	5
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease	5
Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy	5
Measurement of apolipoprotein B levels helps in the identification of patients at risk for hypertriglyceridemic pancreatitis	5
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center	5
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors	5
Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome	5
Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective	4
Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia	4
Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials	4
The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia	4
Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review	4
Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia	4
Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study	4
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease	4

BIO89-100, a GlycoPEGylated FGF21 Analog, Improved Serum Lipids and Extended Half-Life in a Controlled Single Ascending Dose Trial in Healthy Subjects†	4
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system	4
Identifying reference values for serum lipids in Chinese children and adolescents aged 6–17 years old: A national multicenter study	4
Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio	4
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease	4
Lipoprotein subtypes after testosterone therapy in transmasculine adolescents	4
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway	4
A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease	4
Monocyte phenotyping and management of lipoprotein X syndrome	4
Genetic variants in SUSD2 are associated with the risk of ischemic heart disease	4
A cautionary tale: Is this APOB whole-gene duplication actually pathogenic?	4
Cardiometabolic risk factors in siblings from a statewide screening program	4
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care	4
Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients	4
Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study	4
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19	4
Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia	4
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	4
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins	3
JCL Roundtable: Global Think Tank on Lipoprotein(a)	3
Severe hypertriglyceridemia secondary to splice-site and missense variants in LMF1 in three patients from Ecuador	3
Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization	3
Family history of diabetes determines the association of HOMA-IR with fasting and postprandial triglycerides in individuals with normal glucose tolerance	3
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia	3
Recommended and observed statin use among U.S. adults – National Health and Nutrition Examination Survey, 2011-2018	3
Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome	3
Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia	3
Evaluating the role of statins in prevention of preeclampsia: deeper insights into maternal cardiometabolic changes	3
Novel PPARG mutation in multiple family members with chylomicronemia	3
Hypercholesterolemia exacerbated by a ketogenic diet	3
Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C	3
Longitudinal changes in HDL-cholesterol concentration are associated with different risk factors in primiparous and nulliparous young women: The NHLBI Growth and Health Study (NGHS)	3
Temporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease	3
†Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment	3
Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD)	3
LDL receptor and pathogen processes: Functions beyond normal lipids	3
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study	3
Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes	3
Comparison of two polygenic risk scores to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects	3
Prevention: The past, present, and future of medicine and society	3
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion	3
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia	3
Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction	3
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients	3
Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis	3
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia	3
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)	3
The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study	3
JCL roundtable: Healthy ethnic diets	3
Reduced Expression of Angiopoietin-Like Protein 3 via RNA Interference with ARO-ANG3 Produces Prolonged Reductions in LDL-C and Triglycerides in Dyslipidemic Patients	3
Statins, lipids and dementia?	3
Quantifying the contribution of lipoprotein(a) to all apoB containing particles	3
Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men	3
A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans	3
Genetic basis and hematologic manifestations of sitosterolemia in a group of Turkish patients	2
Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice	2
Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction	2
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis	2
Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials	2
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	2
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019	2
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	2
Direct LDL-C estimation in preschoolers: Practicable first step for FH screening	2
A novel homozygous nonsense variant of LMF1 in pregnancy-induced hypertriglyceridemia with acute pancreatitis	2
In vitro fertilization and hypertriglyceridemic pancreatitis: Case report	2
Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia	2
Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome	2
Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)	2
Statin therapy for primary prevention in women: What is the role for coronary artery calcium?	2
First clinical experiences with inclisiran in a real-world setting	2
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI	2
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease	2
Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation	2
JCL roundtable: Low-carbohydrate diets	2
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis	2
ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia	2
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit	2
Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome	2
Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model	2
The independent associations of anti-Müllerian hormone and estradiol levels over the menopause transition with lipids/lipoproteins: The Study of Women's health Across the Nation	2
BIO89-100, a novel glycoPEGylated FGF21 Analog, Demonstrates Triglyceride Reduction and Broad Metabolic Effects in Spontaneously Diabetic Obese Cynomolgus Monkeys	2
Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor	2
Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study	2
Progressively decreasing plasma high-density lipoprotein cholesterol levels preceding diagnosis of smoldering myeloma	2
Association of demographic and health characteristics with circulating oxysterol concentrations	2
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial	2
Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935–2020)	2
Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study	2
The Effect of Estrogen and Testosterone on Cholesterol Crystallization	2
Cardiovascular Mortality and Hospitalization Risk with LDL by CKD Stage in African-American and White US Veterans	2
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived	2
The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia	2
Contribution of hypertriglyceridemia to ischemic cardiovascular disease in Korean women: A nationwide population-based study	2
Normal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene	2
Successful treatment of a patient with mitochondrial myopathy with alirocumab	2